{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:55:06Z","timestamp":1794257706801,"version":"4.9.0"},"reference-count":70,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"unspecified","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"National Institutes of Health, National Institute of Drug Abuse","award":["1R01DA053241-01A1"],"award-info":[{"award-number":["1R01DA053241-01A1"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2023,5,10]]},"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Obesity and smoking are the two leading causes of preventable death in the USA. Unfortunately, most smokers gain weight after quitting. Postcessation weight gain (PCWG) is frequently cited as one of the primary barriers to a quit attempt and a common cause of relapse. Further, excessive PCWG may contribute to the onset or progression of metabolic conditions, such as hyperglycaemia and obesity. The efficacy of the current treatments for smoking cessation is modest, and these treatments have no clinically meaningful impact on mitigating PCWG. Here, we outline a novel approach using glucagon-like peptide 1 receptor agonists (GLP-1RA), which have demonstrated efficacy in reducing both food and nicotine intake. This report describes the design of a double-blind, placebo-controlled, randomised clinical trial that evaluates the effects of the GLP-1RA exenatide as an adjunct to nicotine patches on smoking abstinence and PCWG.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>The study will be conducted at two university-affiliated research sites in Houston, Texas, the UTHealth Center for Neurobehavioral Research on Addiction and Baylor College of Medicine Michael E. DeBakey VA Medical Centre. The sample will consist of 216 treatment-seeking smokers with pre-diabetes (haemoglobin A1c of 5.7%\u20136.4%) and\/or overweight (body mass index of 25 kg\/m<jats:sup>2<\/jats:sup> or above). Participants will be randomised (1:1) to receive subcutaneous injections of placebo or 2\u2009mg exenatide, once weekly for 14 weeks. All participants will receive transdermal nicotine replacement therapy and brief smoking cessation counselling for 14 weeks. The primary outcomes are 4-week continuous abstinence and changes in body weight at the end of treatment. The secondary outcomes are (1) abstinence and changes in body weight at 12 weeks post end of treatment and (2) changes in neuroaffective responses to cigarette-related and food-related cues as measured by electroencephalogram.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Ethics and dissemination<\/jats:title>\n                  <jats:p>The study has been approved by the UTHealth Committee for the Protection of Human Subjects (HSC-MS-21-0639) and Baylor College of Medicine Institutional Review Board (H-50543). All participants will sign informed consent. The study results will be disseminated via peer-reviewed publications and conference presentations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>\n                     <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05610800\">NCT05610800<\/jats:ext-link>.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-072707","type":"journal-article","created":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T13:41:43Z","timestamp":1686750103000},"page":"e072707","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Exenatide as an adjunct to nicotine patch for smoking cessation and prevention of postcessation weight gain among treatment-seeking smokers with pre-diabetes and\/or overweight: study protocol for a randomised, placebo-controlled clinical trial"],"prefix":"10.1136","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct05610800","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05610800","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5639-8802","authenticated-orcid":false,"given":"Luba","family":"Yammine","sequence":"first","affiliation":[{"name":"Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D","family":"Verrico","sequence":"additional","affiliation":[{"name":"Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas, USA"},{"name":"Michael E DeBakey VA Medical Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Versace","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather E","family":"Webber","sequence":"additional","affiliation":[{"name":"Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Suchting","sequence":"additional","affiliation":[{"name":"Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F","family":"Weaver","sequence":"additional","affiliation":[{"name":"Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R","family":"Kosten","sequence":"additional","affiliation":[{"name":"Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas, USA"},{"name":"Michael E DeBakey VA Medical Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husein","family":"Alibhai","sequence":"additional","affiliation":[{"name":"University of Houston, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M","family":"Cinciripini","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D","family":"Lane","sequence":"additional","affiliation":[{"name":"Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy M","family":"Schmitz","sequence":"additional","affiliation":[{"name":"Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"key":"2025101814110029000_13.6.e072707.1","unstructured":"Fryar C , Afful J . Prevalence of overweight, obesity, and severe obesity among adults aged 20 and over: United States, 1960\u20131962 through 2017\u20132018. NCHS Health E-Stats 2020."},{"key":"2025101814110029000_13.6.e072707.2","unstructured":"Smoking cessation: a report of the surgeon general. 2020. Available: https:\/\/www.cdc.gov\/tobacco\/data_statistics\/sgr\/2020-smoking-cessation\/?s_cid=OSH_misc_m180"},{"key":"2025101814110029000_13.6.e072707.3","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e4439","article-title":"Weight gain in Smokers after quitting cigarettes: meta-analysis","volume":"345","author":"Aubin","year":"2012","journal-title":"BMJ"},{"key":"2025101814110029000_13.6.e072707.4","doi-asserted-by":"crossref","DOI":"10.1038\/nrendo.2016.171","article-title":"Metabolic effects of smoking cessation","volume":"12","author":"Harris","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"2025101814110029000_13.6.e072707.5","doi-asserted-by":"publisher","DOI":"10.1136\/tobaccocontrol-2012-050912"},{"key":"2025101814110029000_13.6.e072707.6","doi-asserted-by":"publisher","DOI":"10.1080\/14622200125675"},{"key":"2025101814110029000_13.6.e072707.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4603(98)00014-8"},{"key":"2025101814110029000_13.6.e072707.8","doi-asserted-by":"publisher","DOI":"10.1006\/pmed.1993.1021"},{"key":"2025101814110029000_13.6.e072707.9","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntz010"},{"key":"2025101814110029000_13.6.e072707.10","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1056\/NEJMoa1803626","article-title":"Smoking cessation, weight change, type 2 diabetes, and mortality","volume":"379","author":"Hu","year":"2018","journal-title":"N Engl J Med"},{"key":"2025101814110029000_13.6.e072707.11","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1002\/oby.21582","article-title":"The effect of tobacco cessation on weight gain, obesity, and diabetes risk","volume":"24","author":"Bush","year":"2016","journal-title":"Obesity"},{"key":"2025101814110029000_13.6.e072707.12","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-152-1-201001050-00005"},{"key":"2025101814110029000_13.6.e072707.13","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjr.0000239474.41379.79"},{"key":"2025101814110029000_13.6.e072707.14","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S2213-8587(15)00316-2","article-title":"Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis","volume":"3","author":"Pan","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025101814110029000_13.6.e072707.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.idairyj.2009.11.014"},{"key":"2025101814110029000_13.6.e072707.16","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.490160110"},{"key":"2025101814110029000_13.6.e072707.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(96)00434-4"},{"key":"2025101814110029000_13.6.e072707.18","doi-asserted-by":"publisher","DOI":"10.1002\/cne.902710405"},{"key":"2025101814110029000_13.6.e072707.19","doi-asserted-by":"publisher","DOI":"10.2337\/db14-0849"},{"key":"2025101814110029000_13.6.e072707.20","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-018-0016-2"},{"key":"2025101814110029000_13.6.e072707.21","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5"},{"key":"2025101814110029000_13.6.e072707.22","doi-asserted-by":"publisher","DOI":"10.1210\/en.2011-1443"},{"key":"2025101814110029000_13.6.e072707.23","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4540"},{"key":"2025101814110029000_13.6.e072707.24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077284","article-title":"The glucagon-like peptide 1 analogue Exendin-4 attenuates the nicotine-induced locomotor stimulation, Accumbal dopamine release, conditioned place preference as well as the expression of locomotor sensitization in mice","volume":"8","author":"Egecioglu","year":"2013","journal-title":"PLoS One"},{"key":"2025101814110029000_13.6.e072707.25","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/ntr\/ntab066","article-title":"Exenatide adjunct to nicotine patch facilitates smoking cessation and may reduce post-cessation weight gain","volume":"23","author":"Yammine","year":"2021","journal-title":"Nicotine & Tobacco Research"},{"key":"2025101814110029000_13.6.e072707.26","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20227"},{"key":"2025101814110029000_13.6.e072707.27","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/add.12895","article-title":"An exploratory short-term double-blind randomized trial of Varenicline versus nicotine patch for smoking cessation in women","volume":"110","author":"Gray","year":"2015","journal-title":"Addiction"},{"key":"2025101814110029000_13.6.e072707.28","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.19284"},{"key":"2025101814110029000_13.6.e072707.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2006.12.017"},{"key":"2025101814110029000_13.6.e072707.30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1017\/jsc.2017.2","article-title":"Factors associated with adherence to transdermal nicotine patches within a smoking cessation effectiveness trial","volume":"13","author":"Handschin","year":"2018","journal-title":"J Smok Cessat"},{"key":"2025101814110029000_13.6.e072707.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2015.07.019"},{"key":"2025101814110029000_13.6.e072707.32","first-page":"1217","article-title":"Treating tobacco use and dependence: 2008 update U.S. public health service clinical practice guideline executive summary","volume":"53","year":"2008","journal-title":"Respir Care"},{"key":"2025101814110029000_13.6.e072707.33","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1037\/1064-1297.13.4.282","article-title":"Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation","volume":"13","author":"Cinciripini","year":"2005","journal-title":"Exp Clin Psychopharmacol"},{"key":"2025101814110029000_13.6.e072707.34","doi-asserted-by":"publisher","DOI":"10.1037\/a0018168"},{"key":"2025101814110029000_13.6.e072707.35","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/jamapsychiatry.2013.678","article-title":"Effects of Varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal","volume":"70","author":"Cinciripini","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"2025101814110029000_13.6.e072707.36","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.69.5.858"},{"key":"2025101814110029000_13.6.e072707.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2004.02.063"},{"key":"2025101814110029000_13.6.e072707.38","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.addbeh.2008.12.008","article-title":"Implementation of a smoking cessation treatment integrity protocol: treatment Discriminability, potency and manual adherence","volume":"34","author":"Collins","year":"2009","journal-title":"Addict Behav"},{"key":"2025101814110029000_13.6.e072707.39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1991.tb01879.x"},{"key":"2025101814110029000_13.6.e072707.40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1988.tb00485.x"},{"key":"2025101814110029000_13.6.e072707.41","doi-asserted-by":"publisher","DOI":"10.1037\/1064-1297.7.4.354"},{"key":"2025101814110029000_13.6.e072707.42","doi-asserted-by":"publisher","DOI":"10.1080\/14622200124218"},{"key":"2025101814110029000_13.6.e072707.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2006.06.028"},{"key":"2025101814110029000_13.6.e072707.44","unstructured":"World Health Organisation . 2008. Available: https:\/\/www.who.int\/nutrition\/publications\/obesity\/WHO_report_waistcircumference_and_waisthip_ratio\/en"},{"key":"2025101814110029000_13.6.e072707.45","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.114.083238"},{"key":"2025101814110029000_13.6.e072707.46","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2002.17"},{"key":"2025101814110029000_13.6.e072707.47","doi-asserted-by":"publisher","DOI":"10.1007\/s10389-006-0024-x"},{"key":"2025101814110029000_13.6.e072707.48","first-page":"22","article-title":"The mini-International neuropsychiatric interview (M.I.N.I): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59 Suppl 20","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"2025101814110029000_13.6.e072707.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2008.06.026"},{"key":"2025101814110029000_13.6.e072707.50","doi-asserted-by":"publisher","DOI":"10.1037\/0022-3514.54.6.1063"},{"key":"2025101814110029000_13.6.e072707.51","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1037\/pha0000450","article-title":"Electrophysiological responses to emotional and cocaine cues reveal individual Neuroaffective profiles in cocaine users","volume":"30","author":"Webber","year":"2022","journal-title":"Exp Clin Psychopharmacol"},{"key":"2025101814110029000_13.6.e072707.52","doi-asserted-by":"crossref","DOI":"10.1111\/psyp.13482","article-title":"Estimating statistical power for event-related potential studies using the late positive potential","volume":"57","author":"Gibney","year":"2020","journal-title":"Psychophysiology"},{"key":"2025101814110029000_13.6.e072707.53","doi-asserted-by":"publisher","DOI":"10.1093\/scan\/nsv143"},{"key":"2025101814110029000_13.6.e072707.54","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-1600.2011.00372.x"},{"key":"2025101814110029000_13.6.e072707.55","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/ntr\/ntx264","article-title":"Brain responses to cigarette-related and emotional images in Smokers during smoking cessation: no effect of Varenicline or bupropion on the late positive potential","volume":"21","author":"Versace","year":"2019","journal-title":"Nicotine Tob Res"},{"key":"2025101814110029000_13.6.e072707.56","doi-asserted-by":"crossref","DOI":"10.1111\/psyp.13309","article-title":"The reality of \"food Porn\": larger brain responses to food-related cues than to erotic images predict cue-induced eating","volume":"56","author":"Versace","year":"2019","journal-title":"Psychophysiology"},{"key":"2025101814110029000_13.6.e072707.57","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0511(99)00044-7"},{"key":"2025101814110029000_13.6.e072707.58","doi-asserted-by":"crossref","unstructured":"Weinberg A , Hajcak G . n.d. Beyond good and evil: the time-course of neural activity elicited by specific picture content. Emotion;10:767\u201382. doi:10.1037\/a0020242","DOI":"10.1037\/a0020242"},{"key":"2025101814110029000_13.6.e072707.59","doi-asserted-by":"publisher","DOI":"10.1111\/psyp.12639"},{"key":"2025101814110029000_13.6.e072707.60","unstructured":"R Development Core Team . A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2020."},{"key":"2025101814110029000_13.6.e072707.61","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2012.705016"},{"key":"2025101814110029000_13.6.e072707.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2013.10.010"},{"key":"2025101814110029000_13.6.e072707.63","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/nts217"},{"key":"2025101814110029000_13.6.e072707.64","first-page":"351","article-title":"Smoking cessation and changes in body mass index: findings from the first randomized cessation trial in a low-income country setting","volume":"19","author":"Ben Taleb","year":"2017","journal-title":"Nicotine Tob Res"},{"key":"2025101814110029000_13.6.e072707.65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151290","article-title":"The relationship between body mass index and post-cessation weight gain in the year after quitting smoking: A cross-sectional study","volume":"11","author":"Krukowski","year":"2016","journal-title":"PLoS One"},{"key":"2025101814110029000_13.6.e072707.66","unstructured":"McElreath R . Statistical Rethinking: a Bayesian course with examples in R and Stan. 2016."},{"key":"2025101814110029000_13.6.e072707.67","article-title":"Boca Raton","volume":"178","year":"2015","journal-title":"J R Stat Soc Ser A Stat Soc"},{"key":"2025101814110029000_13.6.e072707.68","unstructured":"Stan Development . Rstan: the R interface to Stan. R package version 2192. 2019."},{"key":"2025101814110029000_13.6.e072707.69","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v080.i01"},{"key":"2025101814110029000_13.6.e072707.70","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1927"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-072707","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:11:14Z","timestamp":1760821874000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-072707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":70,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6,14]]},"published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.1136\/bmjopen-2023-072707"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-072707","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/bmjopen-2023-072707.supp1","asserted-by":"subject"}]},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]}}}